DECEMBER 2020 | EYEWORLD | 105
C
Contact
Gupta:
preeyakgupta@gmail.com
Latkany:
relief@dryeyedoctor.com
Yeu: eyeulin@gmail.com
said. Others who are not comfortable have been
triaged or seen through telehealth appointments
with one of the ODs within her practice.
Dr. Yeu has also found that she's been using
more dry eye disease anti-inflammatory treat-
ments. She said her practice is back to offering
lid margin in-office treatments, which has been
welcomed by both patients and clinicians. "Ap-
proximately 25% of my cataract surgery evalua-
tion patients undergo some in-office lid margin
therapy, most often being biofilm blepharoexfo-
liation in the blepharitis and MGD patients," Dr.
Yeu said.
or if patients aren't willing to leave their homes,
he has found prescription medication options
such as Cequa (cyclosporine, Sun Ophthalmics),
Restasis (cyclosporine, Allergan), and Xiidra
(lifitegrast, Novartis) are helpful.
"While eyecare is considered elective,
patients deem their ocular health and vision to
be essential components to their overall health,"
Dr. Yeu said. "In conjunction, we have made
significant efforts to help support patient care
in the COVID era, including greater automa-
tion of pre-visit paperwork, social distancing
throughout the clinic, mask requirements for all
patients/staff, and limitation of people within
the facility."
This has allowed patients to feel comfort-
able presenting to their appointments, Dr. Yeu
Relevant disclosures
Gupta: None
Latkany: None
Yeu: None
This photograph demonstrates the utility of cell phone cameras in augmenting the telehealth dry eye experience. As demonstrated, the quality
of the image is enough to see that the patient has diffuse collarettes (cylindrical dandruff at base of upper lid margin), indicative of severe
Demodex blepharitis. There is significant misdirection of lashes as a result as well.
Source: Elizabeth Yeu, MD
